Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

NIH accepts clinical study of Zestra

July 27, 2005

Novel PPARalpha agonist demonstrates superior lipid-lowering effects

July 26, 2005

PSN-357 for diabetes begins phase I trial

July 26, 2005

Recent patents disclose novel agents for treating diabetes

July 25, 2005

Therapeutic agents for osteoporosis jointly reported by Novartis and Signal researchers

July 25, 2005

Phase IIb trial of cetilistat in obese diabetics completes enrollment

July 25, 2005

Alkermes and Lilly begin phase III study of inhaled insulin system

July 22, 2005

FDA requests more information to complete NE-180 IND review

July 22, 2005

Hemospan begins new phase II surgical blood loss trial

July 22, 2005

Novel agents for premature ejaculation in development at Pfizer

July 21, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...